Figure 3: a. Time to and cumulative incidence of T-cell donor chimerism in patients treated with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). b. Time to and cumulative incidence of T-cell chimerism in patients who developed grades 0-I acute GVHD and those who developed grades II-IV acute GVHD.